Fangzhen Luo

Dr. Fangzhen Luo

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 December 2021 in Journal of Cellular and Molecular Medicine
Verified
Journal Article
Open access
PDF file
FLFangzhen Luo
Fangzhen Luo
YWYating Wen
Yating Wen
LZLanhua Zhao
Lanhua Zhao
SSShengmei Su
Shengmei Su
YZYuqi Zhao
Yuqi Zhao
ZLZhongyu Li
Zhongyu Li
Chlamydia trachomatis persistent infection is the leading cause of male prostatitis and female genital tract diseases. Inhibition of host cell apoptosis is the key to maintaining Chlamydia survival in vivo, and long noncoding RNAs (lncRNAs) play important roles in its developmental cycle and pathogenesis. However, it is not clear how lncRNAs regulate persistent Chlamydia infection. Here, using a microarray method, we identified 1718 lncRNAs and 1741 mRNAs differentially expressed in IFN‐γ‐induced persistent C. trachomatis infection. Subsequently, 10 upregulated and 5 downregulated differentially expressed lncRNAs were verified by qRT–PCR to confirm the reliability of the chip data. The GO and KEGG analyses revealed that differentially regulated transcripts were predominantly involved in various signalling pathways related to host immunity and apoptosis response. Targeted silencing of three lncRNAs (MIAT, ZEB1‐AS1 and IRF1) resulted in increased apoptosis rates. Furthermore, interference with lncRNA MIAT caused not only an obvious downregulation of the Bcl‐2/Bax ratio but also a marked release of cytochrome c, resulting in a significantly elevated level of caspase‐3 activation. Meanwhile, MIAT was involved in the regulation of chlamydial development during the persistent infection. Collectively, these observations shed light on the enormous complex lncRNA regulatory networks involved in mitochondria‐mediated host cell apoptosis and the growth and development of C. trachomatis.

24 February 2026 in Microorganisms
Verified
Journal Article
Open access
PDF file
LLLingjie Li
Lingjie Li
翌向翌韬 向
翌韬 向
煜蔡煜杰 蔡
煜杰 蔡
FLFangzhen Luo
Fangzhen Luo
MicroRNAs (miRNAs) are essential post-transcriptional regulators of gene expression and have emerged as key modulators of host–pathogen interactions during bacterial infection. In this narrative review, we synthesize recent experimental and mechanistic evidence on how infection-responsive miRNAs shape innate and adaptive immunity, focusing on four representative pathogens: Salmonella, Listeria monocytogenes, Mycobacterium tuberculosis, and Helicobacter pylori. We highlight major miRNA-regulated signaling modules, including TLR/NF-κB, JAK–STAT, autophagy, immunometabolic reprogramming, and extracellular vesicle mediated intercellular communication, and summarize experimentally validated miRNA–target interactions that calibrate immune activation thresholds and inflammatory outcomes. Accumulating evidence indicates that miRNAs not only fine-tune host defense programs by controlling immune-related gene expression and immune cell activation, but can also be exploited by bacterial pathogens to suppress antimicrobial signaling and promote intracellular survival or persistent colonization. Collectively, these findings position miRNAs as a critical regulatory layer linking immune signaling networks to infection outcomes and underscore their translational potential as biomarkers and host directed therapeutic targets, while remaining grounded in current experimental evidence.
1

1 August 2025 in RSC Pharmaceutics
Verified
Journal Article
Open access
PDF file
HLHuiling Liu
Huiling Liu
ZLZhonghui Luo
Zhonghui Luo
FLFangzhen Luo
Fangzhen Luo
XWXilian Wang
Xilian Wang
HWHua Wei
Hua Wei
CYCui-Yun Yu
Cui-Yun Yu
This review summarizes how intratumoral microbiota influence tumor development and explores their potential as targets for drug delivery and immunotherapy enhancement.

23 February 2026 in Frontiers in Public Health
Verified
Journal Article
Open access
PDF file
YLYi Liu
Yi Liu
JWJue Wang
Jue Wang
XWXiaojie Wan
Xiaojie Wan
WPWang Peng
Wang Peng
JGJingwei Guo
Jingwei Guo
YTYunhong Tan
Yunhong Tan
Background: Drug–resistant tuberculosis (DR–TB) remains a major public health challenge in China, yet long–term epidemiological data from key regions such as Hunan Province in South–Central China are still limited. Objective: This study aimed to characterize the epidemiological trends, spatial distribution, and risk factors of Single drug–resistant tuberculosis (SDR–TB), poly–drug–resistant tuberculosis (PDR–TB), multidrug–resistant tuberculosis (MDR–TB), rifampicin–resistant tuberculosis (RR–TB), and isoniazid–resistant tuberculosis (INH–R TB) in Hunan Province between 2014 and 2023, to inform region–specific control strategies. Methods: It was a retrospective analysis that was conducted on 6,597 laboratory–confirmed DR–TB cases. Data were obtained from the Provincial Tuberculosis Control Institute. All patients underwent phenotypic drug susceptibility testing. Independent risk factors for DR–TB subtypes were identified through multivariable logistic regression, with adjusted odds ratios (ORs) and corresponding 95% confidence intervals (CIs) calculated. Results: A total of 6,597 patients with DR–TB were included in this 10–year analysis. Among them, 74.97% were male and 64.44% were farmers. The highest case burden was observed in the 50–59 age group (24.78%). Spatially, cases clustered mainly in the Changsha (16.39%), Shaoyang (13.78%), and Loudi (9.05%). The most common resistance subtypes were INH–R TB (56.27%) and MDR–TB (52.37%). The distribution of all DR–TB subtypes varied significantly across age groups ( p < 0.05), with peaks in middle–aged and older adults. Over time, the detection rate of MDR–TB was highest in 2018, while RR–TB remained the most frequently detected resistance type. Multivariable analysis identified significant regional and demographic disparities. The eastern region of Hunan was associated with an increased risk of SDR–TB (OR = 1.334) and PDR–TB (OR = 1.208), whereas the western region carried the highest risk for MDR–TB (OR = 1.734). Female patients consistently showed lower risks of MDR–TB (OR = 0.819) and RR–TB (OR = 0.784) compared with males. Conclusion: This study presents a 10–year epidemiological assessment of DR–TB in Hunan Province, China, covering 2014–2023. A disproportionately high burden was observed among middle–aged and older male farmers. The predominance of INH–R TB and MDR–TB, together with distinct regional and demographic risk profiles, underscores an urgent need to strengthen TB control measures. These results support the implementation of targeted interventions, including intensified screening in high–risk populations and in high–incidence areas, along with optimized treatment regimens, to curb the ongoing DR–TB epidemic in South–Central China.

29 March 2023 in Research Square
Verified
Preprint
Open access
PDF file
FLFangzhen Luo
Fangzhen Luo
ZLZhongyu Li
Zhongyu Li
Persistent Chlamydia trachomatis infection is a risk factor for tubal infertility, and the pathology is largely due to the inflammatory response; however, the underlying molecular mechanism remains to be elucidated. MAP4K4, which has been implicated in inflammation, was upregulated in Chlamydia persistent infection in our previous study. Here, we employed both in vitro and in vivo models to evaluate the role of MAP4K4 in Chlamydia infection. We demonstrated that MAP4K4 promoted Chlamydia infectivity and increased survival in the genital tract of mice and had a palliative effect on acute inflammation. Additionally, it was beneficial to the development of chronic oviduct lesions. Mechanistically, MAP4K4 downregulated cytokine secretion, regulating the bactericidal effect of the inflammatory response. In addition, MAP4K4 negatively regulates T cell immunity by reducing the proportion of CD8+ T cells and the secretion of IFN-γ and TNF-α by T cells. Thus, these data suggest that MAP4K4 is essential in regulating the host immune response that controls Chlamydia replication, driving the inflammation that causes complications such as infertility. This work provides a novel target for adjuvant therapy of Chlamydia infection.

27 October 2026 in Biomolecules
Verified
Journal Article
Open access
PDF file
翌向翌韬 向
翌韬 向
WCWeisheng Chen
Weisheng Chen
YXYina Xuan
Yina Xuan
GCGuangying Chen
Guangying Chen
LYLi Yu
Li Yu
FLFangzhen Luo
Fangzhen Luo
Although Acinetobacter baumannii, Klebsiella pneumoniae, and Pseudomonas aeruginosa are all classified as carbapenem-resistant, they differ in how they control antibiotic access to its targets. This narrative review concerns resistant clinical isolates. It compares β-lactamases, drug uptake and efflux, and penicillin-binding proteins (PBPs), including their implications for β-lactam treatment. We use enzyme–transport–target architecture to describe functional relationships among these components in a specified organism and drug context. Evidence from the examined systems links protein homeostasis to enzyme stability, transport alterations to drug-specific responses, and treatment to changes in resistance determinants and bacterial population composition. For example, a PBP3 substitution increased the sulbactam–durlobactam MIC eightfold in an Acinetobacter baylyi model, whereas another substitution altered purified-protein reactivity without increasing the MIC. Clinical treatment evidence is assessed separately from these mechanistic findings. The review distinguishes pathogen-focused trials, observational outcomes and in vitro activity, and relates treatment options to carbapenemase class, susceptibility and infection site. It helps explain why shared resistance determinants can produce different susceptibility profiles by linking enzyme activity, drug access and target engagement to the response to specific β-lactams.